Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies

Since the emergence of SARS-CoV-2 at the end of 2019, 64 candidate vaccines are in clinical development and 173 are in the pre-clinical phase. Five types of vaccines are currently approved for emergency use in many countries (Inactivated, Sinopharm; Viral-vector, Astrazeneca, and Gamaleya Research I...

Full description

Bibliographic Details
Main Authors: Ahmed Kandeil, Ahmed Mostafa, Rehab R. Hegazy, Rabeh El-Shesheny, Ahmed El Taweel, Mokhtar R. Gomaa, Mahmoud Shehata, Marawan A. Elbaset, Ahmed E. Kayed, Sara H. Mahmoud, Yassmin Moatasim, Omnia Kutkat, Noha N. Yassen, Marwa E. Shabana, Mohamed GabAllah, Mina Nabil Kamel, Noura M. Abo Shama, Mohamed El Sayes, Amira N. Ahmed, Zahraa S. Elalfy, Bassim MSA Mohamed, Safa N. Abd El-Fattah, Hazem Mohamed El Hariri, Mona Abdel Kader, Osama Azmy, Ghazi Kayali, Mohamed A. Ali
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Vaccines
Subjects:
SARS-CoV-2
pre-clinical study
vaccine safety
immunogenicity
efficacy
Online Access:https://www.mdpi.com/2076-393X/9/3/214

Internet

https://www.mdpi.com/2076-393X/9/3/214

Similar Items